Compared to these models, our prognostic nomogram was based on early laboratory parameters and incorporated two novel prognostic biomarkers: an angiogenetic growth factor, HB-EGF, and a representative cardio-microRNA, hsa-miR-195, which was previously reported as a risk prognostic factor for COVID-19 severity [16]. The gene discussed is HBEGF; the disease is COVID-19.